KELLI PAYNE: Open Payments
NPI 1366046195 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 91 payments from 16 companies in 2025. Trend: 2023 $483 · 2024 $1,546 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $290 |
| ACADIA Pharmaceuticals Inc | 10 | $233 |
| PFIZER INC. | 20 | $206 |
| UCB, Inc. | 14 | $175 |
| Biogen, Inc. | 4 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $79 |
| Genentech USA, Inc. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Eisai Inc. | 2 | $63 |
| ARGENX US, INC. | 2 | $60 |
Products named: NUPLAZID, NURTEC ODT, UBRELVY, Briviact, Leqembi, INGREZZA, BOTOX, KESIMPTA.
Industry payments across AL — which companies pay providers there.
